Cargando…
Cell survival pathways targeted in rare lung disease affecting women
Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.
Autores principales: | Yang, Bennett, Moss, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171799/ https://www.ncbi.nlm.nih.gov/pubmed/37163598 http://dx.doi.org/10.1126/sciadv.adi1215 |
Ejemplares similares
-
Programmed cell death in trypanosomatids: is it an altruistic mechanism for survival of the fittest?
por: Debrabant, Alain, et al.
Publicado: (2003) -
The “technoscientization” of medicine and its limits: technoscientific identities, biosocialities, and rare disease patient organizations
por: Wehling, Peter
Publicado: (2011) -
Life after death: are trypanosomatids programmed to die for the survival of their partners?
por: Fasel, Nicolas, et al.
Publicado: (2003) -
Coronavirus survival on beach sand: Sun vs COVID-19
por: Efstratiou, Maria Adamantia, et al.
Publicado: (2021) -
Leishmania amastigotes as targets for drug screening
por: Monte-Alegre, Adriano, et al.
Publicado: (2006)